QRON
Price:
$0.069
Market Cap:
$1.24M
Qrons Inc., a biotechnology company, engages in development of biotech products, treatments, and technologies to combat neuronal diseases. Its product candidates include QS100, an injury specific, 3D printable, implantable mesenchymal stem cells (MSCs)-synthetic hydrogel to treat penetrating brain injuries; and QS200, an injectable MSCs-synthetic hydrogel for the treatment of concussions and other diffused axonal injuries. The company was formerly known as BioLabMart Inc. and changed its name to Qrons Inc. in August 2017. Qrons Inc. was incorporated in 2016 and is based in Long Island City, New York.
Industry
Biotechnology
IPO Date
2017-09-12
Stock Exchange
OTC
Ticker
QRON
According to Qrons Inc.’s latest financial reports and current stock price. The company's current ROE is 5.09%. This represents a change of -207.54% compared to the average of -4.74% of the last 4 quarters.
The mean historical ROE of Qrons Inc. over the last ten years is -1127.28%. The current 5.09% ROE has changed -100.45% with respect to the historical average. Over the past ten years (40 quarters), QRON's ROE was at its highest in in the March 2019 quarter at 836.84%. The ROE was at its lowest in in the December 2017 quarter at -6410.51%.
Average
-1127.28%
Median
53.04%
Minimum
-7021.36%
Maximum
312.79%
Discovering the peaks and valleys of Qrons Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.18%
Maximum Annual ROE = 312.79%
Minimum Annual Increase = -108.54%
Minimum Annual ROE = -7021.36%
Year | ROE | Change |
---|---|---|
2024 | 12.61% | -76.22% |
2023 | 53.04% | -3.31% |
2022 | 54.86% | -52.63% |
2021 | 115.79% | 12.44% |
2020 | 102.98% | -67.08% |
2019 | 312.79% | -108.54% |
2018 | -3664.44% | -47.81% |
2017 | -7021.36% | 6.18% |
The current ROE of Qrons Inc. (QRON) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
40.17%
5-year avg
67.85%
10-year avg
-1127.28%
Qrons Inc.’s ROE is greater than Advanced Proteome Therapeutics Corporation (0%), greater than Abivax S.A. (-211.00%), greater than Medigene AG (-58.49%), less than Marizyme, Inc. (218.00%), less than Cell Source, Inc. (30.49%), greater than ProtoKinetix, Incorporated (-71.40%), less than Rasna Therapeutics, Inc. (11.35%), less than RespireRx Pharmaceuticals Inc. (19.21%),
Company | ROE | Market cap |
---|---|---|
0% | $149.63K | |
-211.00% | $461.95M | |
-58.49% | $38.56M | |
218.00% | $39.54K | |
30.49% | $13.52M | |
-71.40% | $2.13M | |
11.35% | $3.09M | |
19.21% | $401.96K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Qrons Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Qrons Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Qrons Inc.'s ROE?
How is the ROE calculated for Qrons Inc. (QRON)?
What is the highest ROE for Qrons Inc. (QRON)?
What is the 3-year average ROE for Qrons Inc. (QRON)?
What is the 5-year average ROE for Qrons Inc. (QRON)?
How does the current ROE for Qrons Inc. (QRON) compare to its historical average?